Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome
Matteo Puccetti(University of Perugia), Stefano Giovagnoli(University of Perugia), Maurizio Ricci(University of Perugia), Claudio Costantini(University of Perugia), Carolina Barola(Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche), Paolo Mosci(University of Perugia), Roberta Galarini(Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche), Simone Moretti(Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche), Monica Borghi(University of Perugia), Marilena Pariano(University of Perugia)
Cited by 49
Related Papers
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
|Nature Communications|2016|232
Biologics, theranostics, and personalized medicine in drug delivery systems
|Pharmacological Research|2024|185
IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis
|PLoS Pathogens|2014|164
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
|Nature Communications|2017|129
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite
|Journal for ImmunoTherapy of Cancer|2022|129